The Doctor Prescribed an Obesity Drug. Her Insurer Called It ‘Vanity.’news2022-05-31T22:23:09+00:00May 31st, 2022|The New York Times|
House Passes Bill to Limit Cost of Insulin to $35 a Monthnews2022-03-31T23:01:42+00:00March 31st, 2022|The New York Times|
Nanotherapy for Immunosuppression May Lead to Diabetes Treatmentnews2022-01-20T18:01:43+00:00January 20th, 2022|Medgadget|
Biden Focuses on How Spending Bill Would Lower Drug Costsnews2021-12-06T23:13:31+00:00December 6th, 2021|The New York Times|
A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked.news2021-11-27T17:41:57+00:00November 27th, 2021|The New York Times|
Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skinnews2021-11-02T15:19:51+00:00November 2nd, 2021|Medical Device News Magazine|
DreaMed Launches its FDA-Cleared Diabetes Management Platform with a Leading U.S. Children’s Hospitalnews2021-10-20T18:01:36+00:00October 20th, 2021|Medical Device News Magazine|
